Malo Clinic announces partnership with Straumann Group

Malo Clinic has just announced a new strategic partnership with the Straumann Group. This collaboration marks a decisive step in the evolution of fully implant-supported oral rehabilitation and reaffirms Malo Clinic’s commitment to clinical excellence, continuous innovation, and the highest standards of patient care.

This decision follows an in-depth assessment conducted by Malo Clinic’s clinical team, which identified the need to evolve toward a new generation of clinical protocols and digital workflows. With the rapid transformation of dentistry driven by technological advancements, new biomaterials, and growing patient expectations, it became clear that the future of full-arch rehabilitation requires an integrated approach built on scientific evidence, technological innovation, and clinical predictability.

A clinical decision focused on better patient outcomes

The new partnership with the Straumann Group stems from a strategic, clinically driven decision: to ensure that Malo Clinic patients continue to benefit from the most advanced, predictable, and safe solutions available today.

“By combining Malo Clinic’s globally recognized clinical expertise — as pioneers of total fixed rehabilitation with only four implants — with Straumann’s digital, scientific, and technological ecosystem, this collaboration will further enhance functional and aesthetic results as well as treatment durability,” said Pedro Alvarez, CEO of Malo Clinic.

For patients, this partnership translates into multiple benefits, including:

  • More predictable, efficient, and personalized full-arch rehabilitation treatments;
  • Integration of next-generation digital workflows, from planning to final outcomes;
  • Improved surgical and prosthetic precision, directly impacting comfort, treatment time, and long-term success;
  • Access to cutting-edge technologies such as advanced smile design, digital planning, AI-supported solutions, and centralized planning and production processes.

Since its foundation, Malo Clinic has been synonymous with pioneering spirit, clinical innovation, and scientific leadership — redefining global standards of oral rehabilitation and transforming the lives of millions of patients worldwide.

This new collaboration with the Straumann Group reflects that same DNA: a commitment to working with global leaders who share the same values of excellence, scientific integrity, and patient focus. “By integrating Straumann’s advanced implant technologies, surfaces, prosthetic solutions, and digital workflows, MALO CLINIC remains at the forefront of innovation, continuously raising the standards of quality and predictability in its treatments,” added the CEO.

From the Straumann Group’s perspective, the collaboration represents a powerful convergence of clinical excellence and technological leadership.

“This partnership brings together Malo Clinic’s proven clinical excellence and data-based full-arch rehabilitation protocols with Straumann’s innovation engine and educational leadership. It is a fusion that will redefine standards and accelerate the adoption of digital workflows across the entire spectrum of implantology. This is just the beginning — the next era of innovation in full-arch rehabilitation and digital dentistry starts now,” said Kiran Malviya, Head of Enterprise Solutions EMEA at Straumann Group.

A platform for the future of full-arch rehabilitation

The partnership will enable the joint development of next-generation clinical protocols, integrating advanced solutions in digitalization, photogrammetry, 24/7 centralized planning, artificial intelligence, and innovative approaches to hard and soft tissue regeneration. This comprehensive approach will create a clinical and digital platform that enhances treatment predictability, efficiency, and personalization.

Additionally, the collaboration includes a strong educational component, promoting continuous training for clinicians and teams to ensure that scientific knowledge and clinical excellence continue to evolve for the benefit of patients.

Leave a Reply